Causes of the change in the rates of mortality and severe complications of diabetes mellitus: 1992-2012
- PMID: 25675404
- PMCID: PMC4327779
- DOI: 10.1097/MLR.0000000000000309
Causes of the change in the rates of mortality and severe complications of diabetes mellitus: 1992-2012
Abstract
Objective: To quantify the causes of the changes in the rates of mortality and select severe complications of diabetes mellitus, type 2 (T2D) among the elderly between 1992 and 2012.
Research design: A retrospective cohort study design based on Medicare 5% administrative claims data from 1992 to 2012 was used. Traditional fee-for-service Medicare beneficiaries, age 65 and older, diagnosed with T2D and living in the United States between 1992 and 2012 were included in the study. Blinder-Oaxaca decomposition was used to quantify the potential causes of the change in the rates of death, congestive heart failure and/or acute myocardial infarction, stroke, amputation of lower extremity and end-stage renal disease between 1992 and 2012.
Results: The number of beneficiaries in the analysis sample diagnosed with T2D increased from 152,191 in 1992 to 289,443 in 2012. Over the same time period, rates of mortality decreased by 1.2, congestive heart failure and/or acute myocardial infarction by 2.6, stroke by 1.6, amputation by 0.6 while rates of end-stage renal disease increased by 1.5 percentage points. Improvements in the management of precursor conditions and utilization of recommended healthcare services, not population composition, were the primary causes of the change.
Conclusions: With the exception of end-stage renal disease, outcomes among Medicare beneficiaries diagnosed with T2D improved. Analysis suggests that persons diagnosed with T2D are living longer with fewer severe complications. Much of the improvement in outcomes likely reflects more regular contact with health professionals and better management of care.
Conflict of interest statement
Figures
Similar articles
-
Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone.JAMA. 2010 Jul 28;304(4):411-8. doi: 10.1001/jama.2010.920. Epub 2010 Jun 28. JAMA. 2010. PMID: 20584880
-
Identifying the causes of the changes in the prevalence patterns of diabetes in older U.S. adults: A new trend partitioning approach.J Diabetes Complications. 2018 Apr;32(4):362-367. doi: 10.1016/j.jdiacomp.2017.12.014. Epub 2018 Jan 6. J Diabetes Complications. 2018. PMID: 29433960 Free PMC article.
-
The growing burden of diabetes mellitus in the US elderly population.Arch Intern Med. 2008 Jan 28;168(2):192-9; discussion 199. doi: 10.1001/archinternmed.2007.35. Arch Intern Med. 2008. PMID: 18227367
-
TRENDS IN THE CARE AND OUTCOMES OF MEDICARE BENEFICIARIES WITH TYPE 2 DIABETES, 2002-2011.Endocr Pract. 2016 Aug;22(8):920-34. doi: 10.4158/EP15807.OR. Epub 2016 Apr 4. Endocr Pract. 2016. PMID: 27042746
-
Gaps in receipt of regular eye examinations among medicare beneficiaries diagnosed with diabetes or chronic eye diseases.Ophthalmology. 2014 Dec;121(12):2452-60. doi: 10.1016/j.ophtha.2014.07.020. Epub 2014 Sep 7. Ophthalmology. 2014. PMID: 25208856 Free PMC article.
Cited by
-
Adherence to Guidelines for Screening and Medication Use: Mortality and Onset of Major Macrovascular Complications in Elderly Persons With Diabetes Mellitus.J Aging Health. 2018 Apr;30(4):503-520. doi: 10.1177/0898264316684270. Epub 2016 Dec 21. J Aging Health. 2018. PMID: 28553792 Free PMC article.
-
Global trends in diabetes complications: a review of current evidence.Diabetologia. 2019 Jan;62(1):3-16. doi: 10.1007/s00125-018-4711-2. Epub 2018 Aug 31. Diabetologia. 2019. PMID: 30171279 Review.
-
The Effect of Adherence to Screening Guidelines on the Risk of Alzheimer's Disease in Elderly Individuals Newly Diagnosed With Type 2 Diabetes Mellitus.Gerontol Geriatr Med. 2018 Nov 13;4:2333721418811201. doi: 10.1177/2333721418811201. eCollection 2018 Jan-Dec. Gerontol Geriatr Med. 2018. PMID: 30450369 Free PMC article.
-
Improving health outcomes of people with diabetes: target setting for the WHO Global Diabetes Compact.Lancet. 2023 Apr 15;401(10384):1302-1312. doi: 10.1016/S0140-6736(23)00001-6. Epub 2023 Mar 14. Lancet. 2023. PMID: 36931289 Free PMC article.
-
Major amputations in type 2 diabetes between 2001 and 2015 in Spain: regional differences.BMC Public Health. 2020 Jan 14;20(1):54. doi: 10.1186/s12889-019-8137-7. BMC Public Health. 2020. PMID: 31937275 Free PMC article.
References
-
- Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice. 2010;87:4–14. - PubMed
-
- Wild S, Roglic G, Green A, et al. Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–1053. - PubMed
-
- Zimmet P, Alberti K, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782–787. - PubMed
-
- Centers for Disease Control. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta, GA: U.S. Department of Health and Human Services; 2014.